Candan Karabagli
Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa
The Hague, The Netherlands
Candan Karabagli is a seed investor at GS Yuasa in The Hague focused on Biotechnology and Analytics. Candan Karabagli - Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Candan Karabagli invests in
Stages Candan Karabagli invests in
Countries Candan Karabagli invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $280k–$1.1M
Investment Focus
Industry
- Biotechnology 2 (33%)
- Analytics 1 (17%)
- Biopharma 1 (17%)
- Life Science 1 (17%)
- Manufacturing 1 (17%)
Stage
- Seed 2 (33%)
- Angel 1 (17%)
- Series A 1 (17%)
- Funding Round 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PhiTech Bioinformatics
|
PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $1.1M / Seed / Mar 08, 2024 | |
|
PhiTech Bioinformatics
|
PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K / Mar 22, 2023 | |
|
PhiTech Bioinformatics
|
PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K / Angel / Mar 22, 2023 | |
|
PhiTech Bioinformatics
|
PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K / Seed / Mar 22, 2023 | |
Biolive
|
BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions. | Series A / Mar 02, 2020 | |
Vispera
|
Vispera is an image recognition and analytics company that runs its proprietary technology. With that, we provide retailers and suppliers with the missing insights they need for better performance at all points of sale. The image recognition based automation we provide helps our clients monitor the performance of their in-store execution and takecorrective actions.Our business technology solutions have been shaped into products that help boost productivity for field operations and improve in-store performance of display units. We provide real-time data and guidance on the field team performance, as well as key retail execution metrics such as on-shelf availability, planogram compliance, shelf share, price tag readings, branding material visibility, etc. Among these metrics, problems with on-shelf-availability alone cost the retail sector 1.75 Trillion USD each year. Delivering and commoditizing IR services require expert knowledge which we have. Due to our high performance in accuracy, reporting dashboard flexibility and customer satisfaction we are recently seeing competitors’ clients convert to Vispera services. We maintain our technological edge as well as a robust but flexible product strategy.We want to make image recognition a commodity service for the global retail sector and enable perfect store execution and experience for retailers, suppliers and consumers alike. As such, we progressively move from an IR vendor into retail data analytics provider supported by IR-based evidential reality. | $950K / Seed / Feb 15, 2016 |
Co-Investors
About GS Yuasa
GS Yuasa Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Candan Karabagli
Yönetim Kurulu Başkanı, CHAIRMAN
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Candan Karabagli invest in?
Candan Karabagli invests primarily in Biotechnology, Analytics and Biopharma startups, most often at Seed and Angel stage. Most of the 6 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Candan Karabagli's check size?
Candan Karabagli typically joins rounds of $280k–$1.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Candan Karabagli participates in.
How do I contact Candan Karabagli?
Public channels for Candan Karabagli include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Candan Karabagli last invest?
The most recent investment recorded for Candan Karabagli closed in Mar 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
